Genetic Testing and APOE4

What genes do—and don't—tell you about Alzheimer's risk, what APOE4 means, when genetic testing makes sense, and why counseling matters before you test.

Last reviewed: October 2026

"My mother had Alzheimer's. Will I get it too?" It's one of the most common questions people ask. Genes do play a role—but for most people, they are only part of the story. Here's what you need to know before considering a genetic test.

Two kinds of genes

The Alzheimer's Association describes two categories:

Risk genes raise the chance of developing a disease but don't guarantee it. More than 100 risk genes are suspected to affect late-onset Alzheimer's (age 65 or older), the most common form. The strongest is APOE ε4.

Deterministic genes directly cause disease. For Alzheimer's, three rare genes—APP, PSEN1 and PSEN2—cause familial early-onset Alzheimer's. According to NIA, a child of a parent with one of these variants has a 50/50 chance of inheriting it, and if inherited, a very strong probability of developing Alzheimer's before age 65, sometimes much earlier. These genes account for 1% or less of Alzheimer's cases (Alzheimer's Association). See Young-Onset Dementia.

Understanding APOE

The APOE gene helps make a protein that carries cholesterol and other fats in the bloodstream. Everyone inherits two copies—one from each parent. There are three common forms (NIA):

APOE ε2 — may offer some protection. Roughly 5% to 10% of people have it.
APOE ε3 — the most common form; believed to be neutral.
APOE ε4 — increases risk and is associated with earlier onset in some populations. About 15% to 25% of people carry at least one copy, and 2% to 5% carry two.

Having one ε4 copy raises risk; two copies raise it more. But—and this is crucial—many people with APOE ε4 never develop Alzheimer's, and many people with Alzheimer's don't have APOE ε4 (MedlinePlus Genetics). APOE ε4 is a risk factor, not a diagnosis.

Risk linked to APOE also varies by ancestry. The Alzheimer's Association notes that, in general, people of European ancestry may have higher APOE ε4–related risk than people with some African ancestry. Research is ongoing.

APOE ε4 is also linked to a higher chance of Lewy Body Dementia and heart disease (MedlinePlus).

Family history without a known gene

Most people who develop Alzheimer's do not have a strong family pattern, and family history isn't necessary to develop it. Still, NIA notes that having a parent or sibling with Alzheimer's raises risk compared with people who don't. That increased risk comes from a mix of many genes plus shared lifestyle and environment.

Is genetic testing recommended?

Not routinely. NIA states that genetic tests are not routinely used to diagnose Alzheimer's or predict risk in clinical settings. Situations where testing may be considered include:

Early-onset dementia with a strong family history. A neurologist may order testing for APP, PSEN1 and PSEN2 (NIA).
Before anti-amyloid treatment. For people considering drugs such as Lecanemab (Leqembi) or Donanemab (Kisunla), APOE status matters because people with two copies of APOE ε4 have a higher risk of ARIA—brain swelling or small bleeds that can be serious. FDA labeling recommends APOE ε4 testing before starting lecanemab so patients and doctors can weigh that risk.
Research studies. Many Joining a Clinical Trial test APOE status; some share results with counseling.

Direct-to-consumer tests

Some at-home DNA kits report APOE status without a doctor's order. The Alzheimer's Association urges anyone considering testing to think carefully and to get genetic counseling before testing and when results arrive.

Before you spit in a tube, ask yourself:

What will I do with the result? There is no treatment that removes genetic risk.
How will I feel learning I carry one or two ε4 copies?
Who else is affected? Your result may reveal information about siblings and children.
Insurance. In the U.S., the Genetic Information Nondiscrimination Act (GINA) protects against genetic discrimination in health insurance and most employment, but it does not cover life, disability or long-term care insurance.

A genetic counselor can help you decide and interpret results. You can find one through the National Society of Genetic Counselors.

If you carry APOE ε4

Learning you carry APOE ε4 can be unsettling. Remember:

It raises risk; it doesn't seal your fate.
Healthy habits matter for everyone. Managing blood pressure, staying physically active, protecting hearing, not smoking, limiting alcohol and staying socially engaged all support brain health—see Reducing Dementia Risk: The 14 Risk Factors, Exercise and the Brain and The MIND Diet.
Prevention research often seeks people at higher genetic risk. Ask your doctor or visit trial registries.
Talk with your doctor about any memory concerns rather than assuming the worst.

Bottom line

Genes influence Alzheimer's risk, but for most people they are not destiny. APOE ε4 raises risk; rare genes cause a small number of early-onset cases. Genetic testing is usually not needed for diagnosis but can matter in specific situations, including decisions about anti-amyloid treatment. If you're thinking about testing, start with a conversation with your doctor and a genetic counselor.

Sources

Not medical advice. This article is general information, not a diagnosis or treatment plan for any individual. Talk with a doctor about your situation.

Ask a question

Have a question about memory, Alzheimer's, or caregiving? Email us at:

[email protected]

Open in my email app · Write in Gmail (opens in a new tab)

We may answer common questions in future updates (we won't share your name). We can't give personal medical advice; for urgent help call the Alzheimer's Association Helpline at 800-272-3900.

Memory Digest